Safety Review of Avandia (Rosiglitazone) Description:
FDA offers advice to people who take the diabetes drug Avandia (rosiglitazone) while the agency continues to review data on possible heart-related risks associated with the drug.
Source: www.fda.gov
# posted by Network @ 10:37 PM